These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer]. Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455 [TBL] [Abstract][Full Text] [Related]
3. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study. Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747 [TBL] [Abstract][Full Text] [Related]
4. The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0). Lin WC; Hu FC; Chung SD; Chueh SC; Pu YS; Huang KH J Urol; 2008 Sep; 180(3):879-84; discussion 884-5. PubMed ID: 18635224 [TBL] [Abstract][Full Text] [Related]
5. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for patients with colon or rectal carcinoma treated with resection only. Five-year follow-up report. Tominaga T; Sakabe T; Koyama Y; Hamano K; Yasutomi M; Takahashi T; Kodaira S; Kato T; Ogawa N Cancer; 1996 Aug; 78(3):403-8. PubMed ID: 8697383 [TBL] [Abstract][Full Text] [Related]
7. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818 [TBL] [Abstract][Full Text] [Related]
8. Number and size of lymph nodes recovered from dukes B rectal cancers: correlation with prognosis and histologic antitumor immune response. Murphy J; Pocard M; Jass JR; O'Sullivan GC; Lee G; Talbot IC Dis Colon Rectum; 2007 Oct; 50(10):1526-34. PubMed ID: 17828403 [TBL] [Abstract][Full Text] [Related]
9. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151 [TBL] [Abstract][Full Text] [Related]
10. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261 [TBL] [Abstract][Full Text] [Related]
11. [Lymphatic vessel density in Dukes' B rectal carcinoma and its correlation to prognosis]. Yang X; Li LR; Pan ZZ; Zhou ZW; Wan DS Ai Zheng; 2006 Jun; 25(6):749-52. PubMed ID: 16764774 [TBL] [Abstract][Full Text] [Related]
12. Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer. Mukai M; Sato S; Nishida T; Komatsu N; Shiba K; Nakasaki H; Makuuchi H Oncol Rep; 2003; 10(6):1753-8. PubMed ID: 14534691 [TBL] [Abstract][Full Text] [Related]
13. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760 [TBL] [Abstract][Full Text] [Related]
14. [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection]. Li CS; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Ding PR; Li Y Ai Zheng; 2006 May; 25(5):587-90. PubMed ID: 16687079 [TBL] [Abstract][Full Text] [Related]
15. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Galandiuk S; Wieand HS; Moertel CG; Cha SS; Fitzgibbons RJ; Pemberton JH; Wolff BG Surg Gynecol Obstet; 1992 Jan; 174(1):27-32. PubMed ID: 1729745 [TBL] [Abstract][Full Text] [Related]
16. Depth of mesorectal invasion has prognostic significance in T3N0 low rectal cancer. Tokoro T; Okuno K; Hida J; Ishimaru E; Ueda K; Yoshifuji T Hepatogastroenterology; 2009; 56(89):124-7. PubMed ID: 19453042 [TBL] [Abstract][Full Text] [Related]
17. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. Wang Y; Jatkoe T; Zhang Y; Mutch MG; Talantov D; Jiang J; McLeod HL; Atkins D J Clin Oncol; 2004 May; 22(9):1564-71. PubMed ID: 15051756 [TBL] [Abstract][Full Text] [Related]
18. Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: role of total anatomical dissection. Bokey EL; Ojerskog B; Chapuis PH; Dent OF; Newland RC; Sinclair G Br J Surg; 1999 Sep; 86(9):1164-70. PubMed ID: 10504371 [TBL] [Abstract][Full Text] [Related]
19. Anaemia prior to operation is related with poorer long-term survival in patients with operable rectal cancer. van Halteren HK; Houterman S; Verheij CD; Lemmens VE; Coebergh JW Eur J Surg Oncol; 2004 Aug; 30(6):628-32. PubMed ID: 15256236 [TBL] [Abstract][Full Text] [Related]
20. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate. Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]